University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: PETNET Solutions
Change Order Amount: $1,113,000
This purchase is for radiopharmaceuticals and our requirements have been higher than originally estimated.
The University award process may be delayed up to thirty days as this award goes through a state approval process.
Awarded to:Vendor: PETNET Solutions, Knoxville, TN
Amount: An estimated $500,000
Terms:
An estimated start date of 7/1/2019 through 6/30/2023
Renewals:
None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, April 4, 2019
The University awarded a contract for Radiopharmaceuticals (FDG, Axumin).
Radiopharmaceuticals (FDG, Axumin) are used in cancer diagnosis.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) The Radiopharmaceuticals are critical in cancer diagnosis. Axumin is specifically for recurrent Prostate Cancer after treatment.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.
